Application
LITFL Antibody (N-term) western blot analysis in HepG2 cell line lysates (35ug/lane).This demonstrates the LITFL antibody detected the LITFL protein (arrow).Application
LITFL Antibody (N-term) flow cytometric analysis of HepG2 cells (right histogram) compared to a negative control cell (left histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.| Product Name | C16orf5 Antibody (N-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | C16orf5; CDIP; LITAF-like protein; Cell death-inducing protein; Transmembrane protein I1 |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WBFC |
| WB:1:100~500 FC |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | C16orf5 CDIP LITAFL |
|---|---|
| Alternative Names | C16orf5 CDIP LITAF-like protein Cell death-inducing protein Transmembrane protein I1 |
| Molecular Weight(MW) | 21892 Da |
| Function | Acts as an important p53/TP53-apoptotic effector. Regulates TNF-alpha-mediated apoptosis in a p53/TP53-dependent manner |
| Tissue Specificity | Highly expressed in brain. Expressed at lower level in heart, skeletal muscle, kidney, pancreas and liver Weakly or not expressed in placenta and lung |
| Entrez Gene | 29965 |
|---|---|
| Nucleotide Accession | NP_037531.2 |
Application
LITFL Antibody (N-term) western blot analysis in HepG2 cell line lysates (35ug/lane).This demonstrates the LITFL antibody detected the LITFL protein (arrow).
Application
LITFL Antibody (N-term) flow cytometric analysis of HepG2 cells (right histogram) compared to a negative control cell (left histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.| Application Notes | WB:1:100~500 FC |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
